Acme Universal IPO Review, Financial Analysis & Valuation
In-depth editorial analysis, statutory financial disclosures, and peer valuation metrics to help you evaluate if the Acme Universal IPO is good or bad.
Business Overview
Founded in November 2016, Acme Universal Safezone 9 operates in the Personal Protective Equipment (PPE) segment, manufacturing safety shoes and industrial footwear that protect workers from compression, penetration, electrical shock, static electricity, heat and fire, chemicals, and slipping. Its products cater to a wide range of industries, including construction, oil and gas, mining, heavy engineering, automotive, pharmaceuticals, chemical processing, foundry, and power generation.
Financial Performance
Peer Comparison & Valuation
Compare the valuation of Acme Universal against its listed industry peers to determine if the issue price is justified.
Should you apply for the Acme Universal IPO?
Determining whether the Acme Universal IPO is good or bad requires evaluating the company's financial growth trajectory, the sector's macroeconomic tailwinds, and the premium demanded by the promoters in the price band.
- Review the PAT (Profit After Tax) margins in the financials table above to ensure profitability is not artificially inflated just before the IPO.
- Examine the P/E Ratio in the peer comparison section. A lower P/E relative to industry peers may indicate an undervalued issue.
- Monitor the QIB subscription data on the final day, as heavy institutional buying is a strong indicator of smart-money confidence.